From Awareness to Action: Cancer Prevention & Patient Empowerment

In this episode of MD Newsline, Dr. Aruna Anupindi, a consultant clinical oncologist based in Oxford, UK, joins the podcast to discuss evolving trends in breast and prostate cancer care. Specializing in breast and urological cancers, Dr. Anupindi shares insights from her clinical practice, highlights key takeaways from recent oncology conferences, and reflects on the growing importance of early detection, personalized therapies, and quality of life in cancer treatment. She also addresses disparities in screening uptake, emerging treatment strategies aimed at reducing chemotherapy exposure, and the role of multidisciplinary care teams in supporting patients throughout their cancer journey. Episode Highlights Shifts in Breast and Prostate Cancer Detection Dr. Anupindi discusses increased awareness and earlier diagnosis of prostate cancer, particularly among younger men, driven by public education and PSA testing. She also reflects on breast cancer screening programs and the ongoing challenge of improving participation in minority and underserved communities. Cancer Awareness and Cultural Barriers Drawing from her experience working with South Asian communities, Dr. Anupindi addresses misconceptions around cancer, cultural taboos, and the importance of education in encouraging early screening and timely diagnosis. Younger Patients and Aggressive Disease Biology Younger breast cancer patients often present with more aggressive disease. Dr. Anupindi explains why oncologists tend to take a more proactive treatment approach in this population and highlights the role of hereditary cancer risk and hormonal factors. Key Advances from ESMO and Recent Trials Dr. Anupindi shares highlights from major oncology meetings, including discussions around reducing chemotherapy exposure in HER2-positive and hormone receptor–positive breast cancer. She also explains the clinical significance of trials focused on hormone resistance and targeted combination therapies. Fertility, Pregnancy, and Cancer Treatment The conversation explores data supporting temporary interruption of endocrine therapy for young women wishing to conceive. Dr. Anupindi emphasizes that cancer survivorship should include quality-of-life considerations, including fertility preservation and family planning. Access, Affordability, and Global Equity in Cancer Care Dr. Anupindi compares treatment access across healthcare systems, discussing regulatory pathways, cost considerations, and research into lower-dose therapies that may expand access without compromising outcomes. Technology, AI, and Precision Oncology From artificial intelligence in imaging and pathology to biomarker-driven therapies, Dr. Anupindi reflects on how technology is shaping more precise, efficient, and personalized cancer care. Multidisciplinary Care and Patient Support Team-based care is central to effective oncology treatment. Dr. Anupindi highlights the essential roles of nurses, radiographers, palliative care teams, and support workers in addressing patients' medical, psychological, and social needs. Quality of Life and Patient-Reported Outcomes As cancer treatments extend survival, Dr. Anupindi stresses the growing importance of quality-of-life measures in clinical trials and treatment decision-making, ensuring patients live better, not just longer. Key Takeaway Dr. Anupindi underscores that modern oncology is no longer focused solely on survival outcomes. Early detection, culturally sensitive education, targeted therapies, and quality-of-life considerations are essential to delivering truly patient-centered cancer care. Resources: Website: https://mdnewsline.com/ Newsletter: https://mdnewsline.com/subscribe/ Connect with Dr. Aruna Anupindi:  Here